Conmed (CNMD) Return on Invested Capital (2011 - 2026)

Conmed (CNMD) has 16 years of Return on Invested Capital data on file, last reported at 0.01% in Q2 2026.

• Quarterly Return on Invested Capital fell 47.0% year-over-year to 0.01% in Q2 2026, while the trailing twelve-month figure through Jun 2026 was 0.01% (down 47.0% YoY) and the FY2025 annual result came in at 0.95%, down 134.0% from the prior year.
• Return on Invested Capital retreated to 0.01% in Q2 2026, from 0.26% in the prior quarter.
• In the past five years, Return on Invested Capital ranged from a high of 0.57% in Q4 2024 to a low of 0.0% in Q4 2023.
• A 5-year average of 0.15% and a median of 0.03% in 2022 frame the typical range for Return on Invested Capital.
• Annual changes were most pronounced in 2024 — Return on Invested Capital surged 57 bps — and 2026, when it tumbled 47 bps.
• Tracing CNMD's Return on Invested Capital over 5 years: stood at 0.01% in 2022, then plunged by 74 bps to 0.0% in 2023, then soared by 14524 bps to 0.57% in 2024, then tumbled by 59 bps to 0.24% in 2025, then tumbled by 97 bps to 0.01% in 2026.
• The last three Return on Invested Capital figures came in at 0.01% (Q2 2026), 0.26% (Q1 2026), and 0.24% (Q4 2025), per Business Quant data.